Article
Current pharmacological solutions for Behçet's syndrome.
Expert opinion on pharmacotherapy - 1 Feb 2023
Ozguler Yesim, Esatoglu Sinem Nihal, Hatemi Gulen
Abstract excerpt
INTRODUCTION: Behçet's syndrome (BS) has a heterogeneous clinical phenotype, and its clinical manifestations may respond differently to drugs commonly used to treat BS. The type, dose, and duration of immunomodulatory, immunosuppressive, and biologic agents should be tailored individually. AREAS COVERED: We reviewed the literature for articles on BS management that were published until June 2022 and summarized...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
